in the present paper we show result of a prospective randomized clinical trial carried out to study different morbidities ( f.m . febrile morbidity , u.t.i . urinary tract infections , p.c . pelvic cellulitis , p.a . pelvic abscess , w.i . wound infection ) in a sample of 155 patients undergoing vaginal or abdominal hysterectomy for non malignant disease , divided into three groups . group c , treated with 2 g cefoxitin i.v . in the preoperative period ;
C0042029
urinary tract infections
C0007557
cefoxitin